Literature DB >> 9663255

The plasminogen activator/plasmin system is up-regulated after acute necrotizing pancreatitis in human beings.

H Friess1, R Duarte, J Kleeff, A Fukuda, W H Tang, H Graber, M Schilling, A Zimmermann, M Korc, M W Büchler.   

Abstract

BACKGROUND: Proteolysis and formation of new extracellular matrix components are important mechanisms in tissue remodeling and repair. In this study we analyzed the expression and distribution of the urokinase plasminogen activator (uPA), its membrane receptor (urokinase plasminogen activator receptor [uPAR]), and its inhibitor (plasminogen activator inhibitor-1 [PAI-1]) in acute necrotizing pancreatitis in human beings. In addition, we studied the concomitant expression of transforming growth factor-beta-1 (TGF-beta 1), which is activated by uPA from its precursor and is a potent regulator and stimulator of formation of extracellular matrix.
METHODS: With immunohistochemistry and Northern blot analysis, the expression and cellular distribution of uPA, uPAR, PAI-1, and TGF-beta 1 were determined in 12 normal pancreata obtained from organ donors and 12 pancreatic tissues obtained from patients undergoing operation because of complications of acute necrotizing pancreatitis.
RESULTS: Northern blot analysis showed enhanced expression of uPA, uPAR, and PAI-1 in eight of 12, seven of 12, and nine of 12 necrotizing pancreatitis samples, respectively, compared with normal control samples. In addition, increased TGF-beta 1 mRNA expression was present in eight of 12 necrotizing pancreatitis samples. In contrast, amylase mRNA expression was markedly decreased in the samples of acute necrotizing pancreatitis. Immunohistochemistry revealed elevated uPA, uPAR, and PAI-1 immunoreactivity in the remaining acinar and ductal cells adjacent to the necrotic tissue areas. In contrast, acinar and ductal cells that were located farther from pancreatic necrosis exhibited less uPA and uPAR immunoreactivity. A similar staining pattern in samples of necrotizing pancreatitis was found for TGF-beta 1.
CONCLUSIONS: Up-regulation of uPA and uPAR, which activate proteolysis, might create a milieu that enhances lysis and removal of pancreatic necrosis. The increase in TGF-beta 1 might result from the enhanced catalytic conversion of its precursors by uPA, which subsequently might stimulate formation of extracellular matrix, formation of granulation tissue, and fibrosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9663255

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  7 in total

1.  Connective tissue growth factor is involved in pancreatic repair and tissue remodeling in human and rat acute necrotizing pancreatitis.

Authors:  Fabio F di Mola; Helmut Friess; Erick Riesle; Alexander Koliopanos; Peter Büchler; Zhaowen Zhu; David R Brigstock; Murray Korc; Markus W Büchler
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

2.  Overexpression of Smad2 and colocalization with TGF-beta1 in human pancreatic cancer.

Authors:  J Kleeff; H Friess; P Simon; S Susmallian; P Büchler; A Zimmermann; M W Büchler; M Korc
Journal:  Dig Dis Sci       Date:  1999-09       Impact factor: 3.199

3.  Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis.

Authors:  Ru Chen; Sheng Pan; Kelly Cooke; Kara White Moyes; Mary P Bronner; David R Goodlett; Ruedi Aebersold; Teresa A Brentnall
Journal:  Pancreas       Date:  2007-01       Impact factor: 3.327

4.  Pancreas recovery following cerulein-induced pancreatitis is impaired in plasminogen-deficient mice.

Authors:  Aurelia Lugea; Li Nan; Samuel W French; Jorge A Bezerra; Anna S Gukovskaya; Stephen J Pandol
Journal:  Gastroenterology       Date:  2006-09       Impact factor: 22.682

5.  Suppression of transforming growth factor beta signalling aborts caerulein induced pancreatitis and eliminates restricted stimulation at high caerulein concentrations.

Authors:  Stefan Wildi; Jörg Kleeff; Julia Mayerle; Arthur Zimmermann; Erwin P Böttinger; Lalage Wakefield; Markus W Büchler; Helmut Friess; Murray Korc
Journal:  Gut       Date:  2006-11-29       Impact factor: 23.059

6.  Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker.

Authors:  Özlem Akdoğan; Ayşegül Atak Yücel; Zeynep Gök Sargin; Cemile Sönmez; Güldal Esendağli Yilmaz; Seren Özenirler
Journal:  J Clin Exp Hepatol       Date:  2018-02-16

7.  Serum Urokinase-Type Plasminogen Activator Receptor Does Not Outperform C-Reactive Protein and Procalcitonin as an Early Marker of Severity of Acute Pancreatitis.

Authors:  Witold Kolber; Beata Kuśnierz-Cabala; Paulina Dumnicka; Małgorzata Maraj; Małgorzata Mazur-Laskowska; Michał Pędziwiatr; Piotr Ceranowicz
Journal:  J Clin Med       Date:  2018-09-27       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.